Literature DB >> 23835497

MicroRNA-128 promotes cell-cell adhesion in U87 glioma cells via regulation of EphB2.

Lina Lin1, Xulin Chen, Xuelin Peng, Jianwen Zhou, Hsiang-Fu Kung, Marie C Lin, Songshan Jiang.   

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs which regulate gene expression at the post-transcriptional level. Abnormal expression of miRNAs occurs frequently in human tumors. Despite the fact that reduced expression of miR-128 has been observed in glioma tissues and cells, the role of miR-128 in tumors has not been fully characterized. In the present study, cell adhesion assays indicated that overexpression of miR-128 can promote cell-cell adhesion. Target site prediction algorithms indicated that miR-128 binds the 3'-untranslated regions of erythropoietin-producing hepatocellular receptor (Eph)B1 and EphB2 mRNAs. Luciferase reporter assays confirmed that miR-128 binds and regulates EphB1 and EphB2 mRNAs. Overexpression of EphB2 reduced the ability of miR-128 to promote cell-cell adhesion. The wound-healing assay indicated that miR-128 significantly inhibited cell migration via EphB2. This study revealed the novel functions of miR-128 in cell-cell adhesion and cell migration in glioma cells through the regulation of EphB2, and identified EphB1 and EphB2 as novel miR-128 targets.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23835497     DOI: 10.3892/or.2013.2596

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoE.

Authors:  Chao Shang; Yang Hong; Yan Guo; Yun-Hui Liu; Yi-Xue Xue
Journal:  Oncol Lett       Date:  2015-11-17       Impact factor: 2.967

2.  miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation.

Authors:  X U Zhou; Lin Qi; Shiyu Tong; Y U Cui; Jinbo Chen; Tianxiang Huang; Zhi Chen; Xiong-Bing Zu
Journal:  Oncol Lett       Date:  2015-09-09       Impact factor: 2.967

3.  Infralimbic EphB2 Modulates Fear Extinction in Adolescent Rats.

Authors:  Emmanuel Cruz; Omar Soler-Cedeño; Geovanny Negrón; Marangelie Criado-Marrero; Gladys Chompré; James T Porter
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

4.  miR-128 modulates hepatocellular carcinoma by inhibition of ITGA2 and ITGA5 expression.

Authors:  Xiaohua Zhao; Yingfen Wu; Zhiping Lv
Journal:  Am J Transl Res       Date:  2015-09-15       Impact factor: 4.060

5.  The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.

Authors:  Peng-Hsu Chen; Chia-Hsiung Cheng; Chwen-Ming Shih; Kuo-Hao Ho; Cheng-Wei Lin; Chin-Cheng Lee; Ann-Jeng Liu; Cheng-Kuei Chang; Ku-Chung Chen
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

6.  A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.

Authors:  Chenkai Ma; Hong P T Nguyen; Rodney B Luwor; Stanley S Stylli; Andrew Gogos; Lucia Paradiso; Andrew H Kaye; Andrew P Morokoff
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

7.  Expression of Micro-RNA 128 and Let-7b in Pediatric Acute Lymphoblastic Leukemia Cases

Authors:  Roxan E Shafik; Nahed Abd El Wahab; Salwa A Senoun; Emad Ebeid; Maha A El Taweel
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

8.  A prognostic signature based on three non-coding RNAs for prediction of the overall survival of glioma patients.

Authors:  Junmin Xian; Quanzhong Zhang; Xiwen Guo; Xiankun Liang; Xinhua Liu; Yugong Feng
Journal:  FEBS Open Bio       Date:  2019-03-07       Impact factor: 2.693

Review 9.  The Roles of EphB2 in Cancer.

Authors:  Wei Liu; Chengpeng Yu; Jianfeng Li; Jiwei Fang
Journal:  Front Cell Dev Biol       Date:  2022-02-10

10.  Circ_0000215 Increases the Expression of CXCR2 and Promoted the Progression of Glioma Cells by Sponging miR-495-3p.

Authors:  Nurehemaiti Mutalifu; Peng Du; Jingjing Zhang; Halik Akbar; Baofeng Yan; Sulaiman Alimu; Lingxiao Tong; Xinping Luan
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.